期刊文献+

氯喹对MT01促进大鼠骨髓间充质干细胞增殖作用的影响

Effect of Chloroquine on the Proliferation of Rats Bone Marrow Mesenchymal Stem Cells Irritated by MT01
下载PDF
导出
摘要 目的:通过检测氯喹(chloroquine,CQ)对MT01促进Wistar大鼠骨髓间充质干细胞(BMSCs)增殖的影响,证实MT01可能经由内吞小体对BMSCs细胞生物学性能产生影响。方法:不同工作浓度的CQ与第3代Wistar大鼠BMSCs共培养24、48、72、96h,检测CQ对BMSCs增殖影响的量效和时效关系;在此基础上,加入工作浓度为1mg/L的MT01,MTT法检测不同浓度、不同时间点CQ对MT01作用下BMSCs增殖的影响。结果:适当浓度CQ(4mg/L)具有促进BMSCs增殖的作用;48hCQ刺激BMSCs增殖最明显;低浓度CQ(1mg/L、2mg/L)对MT01促进BMSCs增殖具有抑制作用。结论:CQ对MT01促进BMSCs增殖具有抑制作用,提示MT01可能通过进入BMSCs内吞小体中发挥作用。 Objective:To confirm that MT01 may influence the biological properties of bone marrow mesenchymal stem cells(BMSCs)via endosome by detecting the effect of chloroquine(CQ)on the promotion of Wistar rat BMSCs proliferation by MT01.Methods:The third generation of Wistar rat BMSCs were cultured with different working concentrations of CQ for 24,48,72 and 96hours,in order to detect the effect of CQ on BMSCs proliferation in dose-response relationship and aging relationship.Then,MTT assay was employed to detect the influence of CQ on MT01-stimulated BMSCs proliferation at different concentrations and different time points by adding the 1mg/L working concentration of MT01.Results:Appropriate concentration of CQ(4mg//L)could promote BMSCs proliferation.CQ exhibited the strongest promotion to BMSCs proliferation after 48 hours.Low concentrations of CQ(1mg/L and 2mg/L)inhibited the MT01-mediated promotion of BMSCs proliferation.Conclusion:CQ has an inhibitory effect on the MT01-mediated promotion of BMSCs proliferation,suggesting that MT01 may play a role by entering the endosome in BMSCs.
出处 《口腔医学研究》 CAS CSCD 北大核心 2015年第11期1061-1063,1068,共4页 Journal of Oral Science Research
基金 国家自然科学基金面上项目(编号:81371153) 吉林省科技厅自然科学基金(20150101173JC)
关键词 MT01 氯喹 寡脱氧核苷酸 骨髓间充质干细胞 增殖 MT01 Chloroquine Oligodeoxynucleotide Bone marrow mesenchymal stem cells Proliferation
  • 相关文献

参考文献15

  • 1Yang G, Wan M, Zhang Y, et al. Inhibition of a Crich oli- godeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice [J]. Immunology, 2010, 131(4) : 501-512.
  • 2Yasuda K, Rutz M, Schlatter B, et al. CpG motifindepen- dent activation of TLR9 upon endosomal translocation of " natural" phosphodiester DNA [J]. Eur J Immunol, 2006, 36 (2) : 431-436.
  • 3Shen Y, Feng Z, Lin C, et al. An oligodeoxynucleotide that induces differentiation of bone marrow mesenchymal stem cells to osteoblasts in vitro and reduces alveolar bone loss in rats with periodontitis [J]. Int J Mol Sci, 2012, 13(3) .' 2877-2892.
  • 4申玉芹,孙新华,于丽,于海霞.不同CpG ODN对大鼠骨髓间充质干细胞增殖作用的研究[J].口腔医学研究,2009,25(6):723-725. 被引量:6
  • 5Nagar J, Ranade S, Kamath V, et al. Therapeutic potential of chloroquine in a murine model of inflammatory bowel dis- ease [J]. Int Immunopharmacol, 2014, 21(2) : 328-335.
  • 6Bijker EM, Nganou-Makamdop K, van Gemert GJ, et al. Studying the effect of chloroquine on sporozoite - induced protection and immune responses in Plasmodium berghei ma- laria [J]. Malar J, 2015 Mar 261 14: 130, doi: 10. 1186/ s12936-015-0626-2.
  • 7Joshi P, Chakraborti S, Ramirez-Vick JE, et al. The anti- cancer activity of chloroquine- gold nanopartieles against MCF-? breast cancer cells [J]. Clloids Surf B Biointerfae- es, 2012, 95 : 195-200.
  • 8Tuomela J, Sandholm J, Kauppila JH, et al. Chloroquine has tumor inhibitory and tumor promoting effects in triple negative breast cancer [J]. Oncol Lett, 2013, 6(6) : 1665- 1672.
  • 9Juge N, Moriyama S, Miyaj'i T, et al. Plasmodium falcipa- rum chloroquine resistance transporter is a H + - coupled polyspecifie nutrient and drug exporter [J]. Proc Natl Acad Sci U S A, 2015, 112(11) , 3356-3361.
  • 10Zhou D, Liu Y, Xu L H, et al. Ch]oroquine DifferentiallyModulates Inflammatory Cytokine Expression in RAW 264.7 Cells in Response to Inactivated Staphylococcus aureus [J]. Inflammation, 2015, 38(2) : 745-755.

二级参考文献8

  • 1王学菊,王智博,卫红飞,吴秀丽,王莉,于永利,王丽颖.C型CpG单链寡核苷酸对肿瘤疫苗抑瘤效果的增强作用[J].细胞与分子免疫学杂志,2007,23(4):338-340. 被引量:4
  • 2Nienhuijs ME, Meijer GJ, Merkx MA, et al. Bone substitutes, growth factors and distraction osteogenesis[J].Ned Tijdschr Tandheelkd, 2008, 115(6):297-304.
  • 3KriegAM. Therapeutic potentialof Toll like receptor9 activation [J]. Nat Rev Drug Discov, 2006, 5(6):4712-484.
  • 4Toll-like receptor 9 ligand blocks osteoclast differentiation through induetion of phosphatase[J]. Bone Miner Res, 2007, 22(8) :1301- 1310.
  • 5Vollmer JCpG motifs to modulate innate and adaptive immune responses [J]. Int Rev Immunol, 2006, 25(3-4):125-134.
  • 6Amcheslavsky A, Hemmi H, Akira S, et al. Differential contribution of osteoclast- and osteoblast- lineage cells to CpG - oligodeoxynucleotide (CpG - ODN) modulation of osteoclastogenesis[J]. Bone Miner Res, 2005, 20(9) : 1692- 1699.
  • 7Amcheslavsky A, Bar-Shavit Z. Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides [J]. Cell Physiol, 2006, 207( 1 ) : 244- 250.
  • 8于丽,刘霞,申玉芹,柯小亮,孙宏晨,卢炫谕.腺病毒介导TWEAK对大鼠骨髓间充质干细胞影响的实验研究[J].口腔医学研究,2009,25(1):12-15. 被引量:2

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部